Tumor overexpression of glycoproteins such as mesothelin has mainly been used as a mean of biomarker identification [76], [77], [78], [79], [80], [81], but the study of their functional roles during cancer development remains preliminary [82], [83]. This evidence concerns the gene MSLN and cancer.